Digoxin Toxicity Precipitated by Clarithromycin Use: Case Presentation and Concise Review of the Literature

Canadian Journal of Cardiology

Volumn 27, Issue 6, 2011, Pages 870.e15-870.e16

  Lee, Candace Y W ^a   Marcotte, François ^a   Giraldeau, Geneviève ^a   Koren, Gideon ^b   Juneau, Martin ^a   Tardif, Jean Claude ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL; CAPTOPRIL; CLARITHROMYCIN; DIGOXIN; FUROSEMIDE; GLYCOPROTEIN P; ISOSORBIDE MONONITRATE; MACROLIDE; POTASSIUM; PRAVASTATIN; SPIRONOLACTONE;

ADRENAL DISEASE; AGED; ANOREXIA; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DEHYDRATION; DIZZINESS; DYSLIPIDEMIA; DYSPNEA; EFFUSION; ELECTROCARDIOGRAM; EXERCISE; FATIGUE; HEALTH CARE PERSONNEL; HEART FAILURE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; MALE; NAUSEA; OXYGEN SATURATION; PNEUMONIA; PRECIPITATION; SINUS RHYTHM;

EID: 82155196427     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2011.06.006     Document Type: Article

References (5)

1. Dresser G.K., Bailey D.G. A basic conceptual and practical overview of interactions with highly prescribed drugs. Can J Clin Pharmacol 2002, 9:191-198.
2. Zapater P., Reus S., Tello A., et al. A prospective study of the clarithromycin-digoxin interaction in elderly patients. J Antimicrob Chemother 2002, 50:601-606.
3. Tanaka H., Matsumoto K., Ueno K., et al. Effect of clarithromycin on steady-state digoxin concentrations. Ann Pharmacother 2003, 37:178-181.
4. Gomes T., Mamdani M.M., Juurlink D.N. Macrolide-induced digoxin toxicity: a population-based study. Clin Pharmacol Ther 2009, 86:383-386.
5. Pradax: dabigatran etexilate mesilate. Compendium of Pharmaceuticals and Specialties (e-CPS) Revised October 26, 2010, Accessed June 2, 2011. https://www.e-therapeutics.ca/.